Skip to content
Brilliant Blue Biosciences logoBrilliant BlueBiosciences
Efficiency

Efficiency — what it means and how to control it

Efficiency is the percentage of a treated population that actually receives functional cargo. It is not one number but a chain of four probabilities multiplied together, and the weakest link decides the outcome.

Expression efficiency

60–95%

Reporter-positive cells in HEK293 with optimised lipid reagent

Knockdown

70–90%

mRNA reduction with validated siRNA at 48 h in easy lines

CRISPR indel rate

>80%

RNP electroporation in T cells and iPSCs

Primary immune cells

5–40%

Highly dependent on format — RNP electroporation beats lipids

The four barriers that set the ceiling

Binding: the carrier must attach to the plasma membrane without being washed away by serum proteins. Cationic complexes bind electrostatically to the anionic glycocalyx; the number of particles per cell surface — not the total dose — drives the first step.

Uptake: most non-viral reagents enter through endocytosis, which is clathrin-, caveolin- or macropinocytosis-dependent according to particle size, charge and cell type. Particles smaller than 200 nm favour clathrin routes; larger aggregates drift toward macropinocytosis and often correlate with toxicity.

Endosomal escape: this is the true bottleneck. Under 2% of internalised plasmid typically reaches the cytosol, because cargo is either recycled back to the surface or degraded after endosome–lysosome fusion. Escape strategies are chemistry-specific: the proton sponge effect for PEI, cone-shaped helper lipids such as DOPE for lipoplexes, and ionisable lipid fusion for LNPs.

Nuclear access: plasmid DNA must cross the nuclear envelope, so it is efficient mainly in dividing cells where the envelope transiently disassembles. mRNA, siRNA and RNP act in the cytoplasm and are therefore far less dependent on cell-cycle status — a key reason RNP formats win in non-dividing cells.

How efficiency is actually measured

Different readouts answer different questions. A fluorescent reporter gives the fraction of cells that received cargo; a luminescent reporter (luciferase) gives total protein produced and is more sensitive to strong single-cell expression; qPCR gives transcript levels independent of translation.

Always pair a positive control carried through the same workflow with your test condition. Normalising to a control reagent lets you compare runs and operators instead of chasing absolute percentages that shift with passage number and confluency.

  • Flow cytometry with a fluorescent reporter: report both % positive and median fluorescence intensity (MFI) — the two can move in opposite directions.
  • Luciferase or β-galactosidase reporter assay: total expression output, useful when the payload of interest is a secreted protein.
  • qPCR / RT-qPCR: mRNA-level confirmation; mandatory for siRNA because protein knockdown peaks later than transcript loss.
  • Functional assays: only these prove biology — enzymatic activity, edited-protein readout, or a phenotypic change.

Titrating for efficiency without paying in viability

Efficiency has a maximum in the reagent-to-cargo ratio, and pushing past it usually costs viability rather than gaining delivery. Build a two-dimensional matrix in advance: three reagent volumes × three nucleic-acid amounts in the same plate, with a no-reagent and a no-cargo control in every corner.

Because expression kinetics differ by format, harvest at several timepoints. Plasmid peak expression normally lands at 48–72 h, siRNA at 24–48 h, and CRISPR editing phenotypes often only stabilise at 72–96 h when the residual protein has been diluted by division.

FormatCytoplasmic or nuclear actionExpected peakMain limitation
Plasmid DNANuclear transcription required48–72 hDividing cells only; plasmid dilution
mRNACytoplasmic translation6–24 hTransient; RNase sensitivity
siRNA / miRNACytoplasmic RISC loading24–48 hKnockdown depth varies by target turnover
CRISPR RNPCytoplasmic then nuclear entry48–96 hProtein delivery cost and cargo size

When efficiency goes wrong

High signal in only a few bright cells

Likely cause

Over-complexation; large aggregates delivered to few cells

What to do

Reduce reagent volume 20–30%, filter or re-optimise the DNA:reagent ratio

Uniformly low signal across the plate

Likely cause

Poor complex formation, degraded nucleic acid or serum interference

What to do

Verify A260/A280 ≈ 1.8, form complexes in serum-free medium, check the reagent has not been freeze-thawed

Efficiency collapses at higher passage

Likely cause

Loss of endocytic activity and altered membrane composition

What to do

Return to a low-passage working stock; re-titrate every 10–15 passages

Good reporter signal but no phenotype

Likely cause

Expression without function — misfolding, no cofactor, or silencing

What to do

Move to a functional assay; verify the construct is in-frame and the promoter is active in this cell type

Operating rules for Efficiency

  • Reporter plasmid first — settle efficiency before introducing the payload you care about.
  • Report % positive and MFI together; they answer different questions.
  • Re-titrate whenever cell lot, passage, serum lot or operator changes.
Section 1 of 3Back to the guide